Oncolytic Virus Market
Oncolytic Virus Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Oncolytic Virus Market Size and Growth
The Oncolytic Virus market is poised for significant growth, driven by advancements in gene therapy and immunotherapy. The global market is projected to reach approximately $5.2 billion by 2027, reflecting increasing clinical trials and regulatory approvals for oncolytic virotherapy. Market conditions underscore rising demand for innovative cancer treatments. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Amgen
◍ Oncolytics Biotech
◍ Viralytics
◍ Transgene SA
◍ Oncolys BioPharma
◍ Targovax
◍ PsiOxus Therapeutics
◍ SillaJen Biotherapeutics
◍ Sorrento Therapeutics
◍ Lokon Pharma
◍ Genelux Corporation
◍ Vyriad
◍ TILT Biotherapeutics
◍ Cold Genesys
The oncolytic virus market features companies like Amgen, Oncolytics Biotech, and SillaJen, developing innovative therapies targeting cancer cells. Their advancements contribute to market growth through clinical trials, partnerships, and regulatory approvals. Notable revenues include Amgen's $25 billion (2022) and Oncolytics Biotech's $14.9 million (2022), reflecting increasing demand.
Request Sample Report
Market Segmentation
By Application
Request Sample Report
By Product
Imlygic
Oncorine
Melanoma
Market Growth
Request Sample Report
$ X Billion USD
